The most-cited antidepressant study, re-examined

Preview text: Microdose Pro 96 A story most of us were told about mental health, and what the primary…

Thursday, May 21, 2026 at 6:45 AM EasternKlaviyo

Microdose ProThe most-cited antidepressant study, re-examined

Image not available

No image available for this email.

Subject: The most-cited antidepressant study, re-examined
Preview text: Microdose Pro 96 A story most of us were told about mental health, and what the primary…
From: hello@microdose-pro.com
Brand: Microdose Pro
ESP: Klaviyo
Sent: Thu May 21, 2026, 6:45 AM ET
Size: 46 KB
Images: 4
Links: 11, 1 of them buttons
Subject length: 48 characters

Against Microdose Pro's usual

Sent in its busiest hour, 6 AM, which holds 33% of its emails. The subject is 48 characters; its average is 37.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

from o1287.shared.klaviyomail.com [167.89.80.86] by our receiving server with ESMTPS
by recvd-…-59fnz with SMTP
from (unnamed) by geopod-ismtpd-42 with HTTP

Other sending headers (names only): X-Kmail-Account, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID

	Jun 2, 2026 9:45 AM	The two layers of a microdose protocol
	May 28, 2026 7:00 AM	The substance we never question 🍷
	May 26, 2026 8:02 AM	🧪 Psilocybin is about to be FDA approved. The lab version, that is
	May 21, 2026 6:45 AM	The most-cited antidepressant study, re-examined (this email)
	May 19, 2026 4:45 AM	A quieter approach to microdosing 🍄
	May 13, 2026 9:45 AM	What your GP won't tell you about mushrooms
	May 8, 2026 7:45 AM	Why we have our own farm in Flevoland, the Netherlands.